Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedMajor update: new operating-status notice and a version upgrade to v3.2.0, replacing v3.1.0.SummaryDifference2%
- Check19 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0 with added contact/identifier strings; no clear changes to core content, pricing, or availability.SummaryDifference0.0%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No changes to core content, pricing, stock, or time slots.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has updated its facility name and location details, specifically replacing 'Milano, Italy, 20133' with 'Milan, Italy, 20133', and has added 'cabozantinib' as a new term. Additionally, the revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference0.8%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.